Nifecard
Brand names,
Nifecard
Analogs
Nifecard
Brand Names Mixture
Nifecard
Chemical_Formula
C17H18N2O6
Nifecard
RX_link
http://www.rxlist.com/cgi/generic2/nifedip.htm
Nifecard
fda sheet
Nifecard
msds (material safety sheet)
Nifecard
Synthesis Reference
Bossert, Vater, U.S. Pat. 3,485,847 (1969)
Nifecard
Molecular Weight
346.335 g/mol
Nifecard
Melting Point
172 - 174 oC
Nifecard
H2O Solubility
Insoluble
Nifecard
State
Solid
Nifecard
LogP
2.343
Nifecard
Dosage Forms
Capsule; Tablet; Tablet (extended-release)
Nifecard
Indication
For the management of vasospastic angina, chronic stable angina and hypertension.
Nifecard
Pharmacology
Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.
Nifecard
Absorption
Rapidly and fully absorbed following oral administration.
Nifecard
side effects and Toxicity
Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)
Nifecard
Patient Information
Nifecard
Organisms Affected
Humans and other mammals